Global analysis of Plasmodium falciparum histidine-rich protein-2 (pfhrp2) and pfhrp3 gene deletions using whole-genome sequencing data and meta-analysis. by Sepúlveda, Nuno et al.
LSHTM Research Online
Sepúlveda, N; Phelan, J; Diez-Benavente, E; Campino, S; Clark, TG; Hopkins, H; Sutherland, C;
Drakeley, CJ; Beshir, KB; (2018) Global analysis of Plasmodium falciparum histidine-rich protein-2
(pfhrp2) and pfhrp3 gene deletions using whole-genome sequencing data and meta-analysis. Infection,
genetics and evolution. ISSN 1567-1348 DOI: https://doi.org/10.1016/j.meegid.2018.04.039
Downloaded from: http://researchonline.lshtm.ac.uk/4647728/
DOI: https://doi.org/10.1016/j.meegid.2018.04.039
Usage Guidelines:
Please refer to usage guidelines at https://researchonline.lshtm.ac.uk/policies.html or alternatively
contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by-nc-nd/2.5/
https://researchonline.lshtm.ac.uk
Accepted Manuscript
Global analysis of Plasmodium falciparum histidine-rich
protein-2 (pfhrp2) and pfhrp3 gene deletions using whole-genome
sequencing data and meta-analysis
Nuno Sepúlveda, Jody Phelan, Ernest Diez-Benavente, Susana
Campino, Taane G. Clark, Heidi Hopkins, Colin Sutherland, Chris
J. Drakeley, Khalid B. Beshir
PII: S1567-1348(18)30226-0
DOI: doi:10.1016/j.meegid.2018.04.039
Reference: MEEGID 3505
To appear in: Infection, Genetics and Evolution
Received date: 8 March 2018
Revised date: 24 April 2018
Accepted date: 29 April 2018
Please cite this article as: Nuno Sepúlveda, Jody Phelan, Ernest Diez-Benavente, Susana
Campino, Taane G. Clark, Heidi Hopkins, Colin Sutherland, Chris J. Drakeley, Khalid
B. Beshir , Global analysis of Plasmodium falciparum histidine-rich protein-2 (pfhrp2)
and pfhrp3 gene deletions using whole-genome sequencing data and meta-analysis. The
address for the corresponding author was captured as affiliation for all authors. Please
check if appropriate. Meegid(2018), doi:10.1016/j.meegid.2018.04.039
This is a PDF file of an unedited manuscript that has been accepted for publication. As
a service to our customers we are providing this early version of the manuscript. The
manuscript will undergo copyediting, typesetting, and review of the resulting proof before
it is published in its final form. Please note that during the production process errors may
be discovered which could affect the content, and all legal disclaimers that apply to the
journal pertain.
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
Global analysis of Plasmodium falciparum histidine-rich protein-2 (pfhrp2) and pfhrp3 
gene deletions using whole-genome sequencing data and meta-analysis 
 
Nuno Sepúlveda1,2,*, Jody Phelan1, Ernest Diez-Benavente1, Susana Campino1, 
Taane G. Clark1, Heidi Hopkins1, Colin Sutherland1, Chris J. Drakeley1, Khalid B. 
Beshir1 
 
1 London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 
7HT, United Kingdom 
2 Centre of Statistics and its Applications of University of Lisbon, Faculdade de 
Ciências da Universidade de Lisboa, Bloco C6 - Piso 4, Campo Grande, 1749-016 
Lisboa, Portugal   
 
 
 
 
 
* Corresponding author  
London School of Hygiene and Tropical Medicine 
Keppel Street 
WC1E 7HT London 
United Kingdom 
 
E-mail: nuno.sepulveda@lshtm.ac.uk  
 
  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
Abstract  
Many rapid diagnostic tests (RDT) used on suspected malaria cases are based on 
the detection of the protein encoded by the Plasmodium falciparum histidine-rich 
protein-2 (pfhrp2) gene, which shares a high sequence homology with pfhrp3 in the 
3D7 reference genome. Parasite isolates showing pfhrp2 and pfhrp3 gene deletions 
have been emerging over the years, but a comprehensive genetic analysis of these 
variants is still lacking. With this purpose, genomic data from experimental P. 
falciparum genetic crosses between different laboratory lines (3D7, HB3, DD2, 7G8 
and GB4) were first analysed (n=98). The frequency of pfhrp2 deletions was 
consistent with a Mendelian prediction in HB3 x DD2 (56.7%; 95%CI=(39.5%-
72.9%)). Moreover, the pfhrp2 and pfhrp3 deletions segregated independently of 
each other in the same genetic cross. Analysis of 3D7 x HB3 and 7G8 x GB4 
estimated the probability of spontaneously generating a pfhrp2 deletion during 
sexual recombination to be up to 6.2%. Next, whole genome sequence data from 
1,970 P. falciparum isolates collected globally were analysed. Nine samples 
displayed depth of coverage consistent with pfhrp2 deletions (0.5%), but the 
corresponding split-read analysis could not confirm deletions in seven of these 
samples. Twenty-eight isolates had evidence of pfhrp3 deletions (1.4%), which are 
widespread in Southeast Asia. Finally, a meta-analysis of published data revealed a 
positive mean association between the frequencies of pfhrp2 and pfhrp3 deletions in 
Africa and South America. This result suggested a shared selective pressure acting 
on these genetic variants. In conclusion, evidence of genetic selection on both 
pfhrp2 and pfhrp3 deletions was presented, but experimental crosses do not provide 
evidence of a fitness cost of these variants. Further work is urgently needed to 
accurately determine the prevalence and the degree of association between these 
genetic variants, and the respective impact on diagnostic accuracy of many in-use 
RDT.  
 
Keywords: genetic selection, malaria, rapid diagnostic test, gene deletion, genomic 
data.   
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1. Introduction 
The past decade has witnessed a significant decline in the number of malaria cases 
and related deaths across the globe (WHO | World Malaria Report 2015, 2016). The 
decline has been attributed to many factors including an increased frequency of 
diagnostic tests performed on suspected cases, leading to improvements in access 
to appropriate treatment. Among the diagnostic tools available, rapid diagnostic tests 
(RDT), which comprise a small chromatography cassette that detects parasite-
specific antigens in patient blood, have the advantage of being easily applicable and 
reliable for use in routine clinical and community-based care, including in remote and 
underserved endemic settings. For Plasmodium falciparum infections, the most 
popular RDT are based on the detection of histidine-rich protein-2 (pfhrp2) antigen. 
However, this approach may be compromised by the emergence of P. falciparum 
parasites with deleted pfhrp2. South America was the first region to report the 
occurrence of false negative RDT results due to this gene deletion (Gamboa et al., 
2010; Akinyi et al., 2013; Abdallah et al., 2015; Akinyi Okoth et al., 2015; Murillo 
Solano et al., 2015; Rachid Viana et al., 2017). Similar evidence was followed by 
more recent studies from Africa (Dolo et al., 2012; Wurtz et al., 2013; Parr et al., 
2016; Beshir et al., 2017) and Asia (Kumar et al., 2013; Li et al., 2015; Bharti et al., 
2016). Driven by the high impact of pfhrp2-detecting RDT use on malaria control, 
mathematical modelling exercises have identified low transmission regions of sub-
Saharan Africa as the priority for pfhrp2-deletion investigations (Watson et al., 2017).   
In the P. falciparum genome, pfhrp2 is located in a sub-telomeric region of 
chromosome 8. Genetic variation is a hallmark of this gene due to diferent histidine-
alanine-rich motifs repeated a different number of times in parasite samples 
collected across the globe (Baker et al., 2010). However, deletions of this gene 
appear to be mostly at low frequency in Africa, Asia and Pacific (Baker et al., 2010). 
Interestingly, in the 3D7 reference genome, this gene shares 85-90% homology in 
nucleotide sequence with pfhrp3, located in a sub-telomeric region of chromosome 
13 (Wellems and Howard, 1986).  Such sequence similarity suggests that they 
encode related protein isoforms that have a degree of functional redundancy. Thus, 
in absence of pfhrp2, RDT positivity could be retained due to pfhrp3 expression 
(Baker et al., 2010; Beshir et al., 2017). If this hypothesis is true, both genes, 
although genetically unlinked, would be under a shared selective pressure in P. 
falciparum endemic countries.  
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The location of the two loci in sub-telomeric regions places them among antigenic 
diversity gene families, such as those encoding STEVOR or rifin, which are prone to 
recombination and genomic instability (Bopp et al., 2013). In theory, deletions of 
pfhrp2 and pfhrp3 are then expected to occur more frequently than in other loci in the 
P. falciparum genome.    
To better understand the segregation of these important deletions and their potential 
fitness cost, the present study first analysed whole-genome sequencing data from 
three experimental crosses: 3D7 x HB3, HB3 x DD2, and 7G8 x GB4 (Walliker et al., 
1987; Wellems et al., 1990; Hayton et al., 2008). The analysis of this data was driven 
by the fact that the DD2 and HB3 lines show pfhrp2 and pfhrp3 deletions in their 
genome, respectively (Kemp et al., 1987; Wellems et al., 1987; Baker et al., 2010). 
The cross between 7G8 and GB4 lines, both with intact pfhrp2 and pfhrp3 loci was 
included to calculate the frequency of spontaneously generating deletions of these 
genes during sexual recombination. A global analysis of pfhrp2 and pfhrp3 gene 
deletions was then performed using a large collection of whole-genome sequencing 
data of field isolates from 20 countries. Finally, a meta-analysis of existing data was 
performed to estimate the linkage disequilibrium between pfhrp2 and pfhrp3 gene 
deletions.        
 
2. Methods 
2.1 Genomic data from lab strains and experimental crosses 
A total of 98 publicly available samples was downloaded from the MalariaGEN Pf 
genetic crosses project website (Miles et al., 2016). These samples refer to the 
parental lines 3D7 (n=1), HB3 (n=2), DD2 (n=1), 7G8 (n=1) and GB4 (n=1) and the 
respective progeny from the following experimental crosses: 3D7 x HB3 (n=19), HB3 
x DD2 (n=35), and 7G8 x GB4 (n=38). These lab strains are originally from West 
Africa (3D7), Honduras (HB3), Indochina (DD2), Brazil (7G8) and Ghana (GB4). 
The MalariaGEN Pf community project provides an invaluable resource of whole-
genome sequencing data of field samples (Manske et al., 2012; Miotto et al., 2015). 
In this study, a subset of 1,970 high-quality sequencing data from this project 
(Gomes et al., 2017; Ravenhall et al., 2016) was analysed. The samples represented 
a total of 20 countries (South America 2, Asia/Oceania 8, and Africa 10) with sample 
sizes ranging from 2 (India) to 399 (Cambodia). The raw data and alignment “bam” 
files were processed as described in detail elsewhere (Campino et al., 2016). In 
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brief, each of these whole-genome samples was mapped onto the 3D7 reference 
genome (v3) using bwa-mem. The genome-wide and pfhrp2/3 gene coverage was 
determined using samtools (http://samtools.sourceforge.net/).  
All samples from the genetic crosses and the parental lines had an overall mean 
coverage of at least 20 reads per position (Table 1). Similar overall mean coverage 
was obtained for the field samples (Supplementary Data 1).  Additionally, in both lab 
and field samples, there was an average coverage of 25 reads per position in the 
highly conserved Aldolase and L-lactate dehydrogenase LDH genes 
(Pf3D7_1444800 and Pf3D7_1324900, respectively) which also produce antigens 
targeted by some malaria RDT.  
 
2.2 Detection of pfhrp2/pfhrp3 deletions 
The genomic analysis was focused on 100-kb extended loci of the pfhrp2 and pfhrp3 
genes (from 1,355,000 to 1,455,000 at chromosome 8 and 2,800,000 to 2,900,000 at 
chromosome 13, respectively). The number of reads mapped onto each position 
(e.g., coverage) of these extended loci were determined from the respective bam 
files using samtools (www.htslib.org). As mentioned in the Introduction, pfhrp2 and 
pfhrp3 share high sequence homology in the 3D7 reference genome and, therefore, 
coverage of each sample might be affected by reads that could be mapped onto 
either gene. To understand the extent of this potential problem, the 3D7 nucleotide 
sequences of the two genes were initially aligned using clustal multiple sequence 
alignment by muscle (www.ebi.ac.uk/Tools/msa/muscle/). The respective alignment 
showed differences scattered around these aligned sequences (Supplementary 
Figure 1A). In this scenario, the mapping quality scores were expected to correctly 
assign reads to the corresponding gene. This expectation was confirmed by a kmer 
analysis where almost every position of the 3D7 pfhrp2 and pfhrp3 sequences 
appears to be unique (Supplementary Figure 1B). Hence, the effect of multi-mappers 
on coverage appears to be negligible.  
Since current methods to detect gene deletions using whole-genome sequencing 
data require the analysis of the coverage profile for the whole genome (Boeva et al., 
2012; Sepúlveda et al., 2013), a simple algorithm was implemented in order to 
perform deletion calling of the pfhrp2 and pfhrp3 genes. For each sample, the 
percentage of positions with coverage  two reads was calculated for the coding 
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region of each gene; the two-read cut-off allowed for some coverage at putative 
deletions due to mapping or sequencing errors. Gene deletions were then called out 
in samples where that percentage was at least 75%. A second cut-off of 10 reads 
was used to identify putative polyclonal samples with deleted and non-deleted pfhrp2 
and pfhrp3 genes (i.e., mixed genotype call). To strengthen the call of these mixed 
infections, this analysis was extended to the 1-kb downstream and upstream flanking 
regions of each gene under analysis. A mixed genotype of the pfhrp2 and pfhrp3 
genes was only considered for samples where the same genotype call was obtained 
for the coding regions of these genes and at least one of the respective flanking 
regions. Genotype calls based on larger flanking regions (2.5kb, 5kb and 10kb) were 
also performed, but they only generated consistent results for samples with large 
deletions. To increase the evidence for mixed genotype calls, the alignment files of 
the detected samples were explored with the aim of identifying split reads mapped 
onto the flanking positions defining the putative deleted regions. In this analysis, a 
mix of split reads (e.g., evidence for a deletion) and non-split reads (e.g., evidence 
for a non-deleted region) was expected to map onto these genomic positions.          
Since the above algorithm could generate highly stringent cutoff values to detect 
mixed infections in samples with high depth of coverage, two additional methods 
were used in the analysis. The first one determined a coverage cutoff for each 
sample based on 10% of the median coverage across the genome. This method did 
not perform well, because the cutoff values for calling a deletion or a mixed genotype 
were very close to each other for samples with moderate depth of coverage. As 
expected, a higher number of mixed infections was indeed identified in the field 
samples with a high depth of coverage. However, when the respective coverage 
profiles were visualised, they showed erratic random fluctuations that seemed 
inconsistent with a stable coverage depth expected to be observed in samples with 
mixed infections. The second method was based on a similar idea, but with the cutoff 
values being calculated in the 100-kb extended loci of the pfhrp2 and pfhrp3 genes. 
Again, this method did not show a good performance in the field samples, because 
the cutoff values generated for mixed infections tended to be very too low (median of 
7 reads). 
 
2.3 Meta-analysis of pfhrp2/pfhrp3 deletion status  
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A meta-analysis was performed on published data where the combined status of 
pfhrp2 and pfhrp3 deletions was reported for each sample. These studies were 
sought in PubMed using the following search terms: (‘pfhrp2’, ‘pfhrp3’ and ‘deletion’) 
or (‘hrp2’, ‘hrp3’ and ‘deletion’). This search retrieved a total of 22 studies at the time 
of writing (April 13th, 2018). Of these, six studies were excluded from the analysis, 
because they did not evaluate pfhrp2 and pfhrp3 deletions in the field (Ramutton et 
al., 2012; Mendoza et al., 2013; Das et al., 2018; Parr et al., 2018) or referred to 
case studies (Houzé et al., 2011; Johora et al., 2017). Other six studies determined 
the combined genotypes of pfhrp2 and pfhrp3 status only on a subset of  samples 
with negative RDT result (Kumar et al., 2013; Wurtz et al., 2013; Li et al., 2015;  
Bharti et al., 2016; Parr et al., 2016; Gupta et al., 2017). These studies were 
discarded from the analysis, because the respective data were intrinsically 
incomplete and biased by study design. Meta-analysis was then performed on the 
remaining ten studies. These studies consisted of data from Bolivia (Rachid Viana et 
al., 2017), Brazil (Rachid Viana et al., 2017), Colombia (Murillo Solano et al., 2015; 
Dorado et al., 2016), French Guiana (Trouvay et al., 2013), Guyana (Akinyi Okoth et 
al., 2015), Honduras (Abdallah et al., 2015), Peru (Gamboa et al., 2010), and 
Suriname (Akinyi Okoth et al., 2015) in South America, and from Eritrea (Menegon et 
al., 2017; Berhane et al., 2018), Ghana (Amoah et al., 2016), and Kenya (Beshir et 
al., 2017) in Africa .  
All these studies provided evidence of P. falciparum infections using microscopy and 
PCR amplification. Initial evidence of deletion was confirmed by PCR amplification of 
pfhrp2 and pfhrp3 and their flanking regions to infer the extent of the respective 
deletions. To test the quality of DNA in the samples and confirm the gene deletions, 
further PCR amplification was carried out in other genes, such as the merozoite 
surface protein-1 or -2 genes (Gamboa et al., 2010; Murillo Solano et al., 2015; 
Dorado et al., 2016; Beshir et al., 2017; Rachid Viana et al., 2017). However, the 
recommended antigen analysis based on re-testing the samples with a different 
pfhrp2-based RDT or using an enzyme-linked immunosorbent assay to quantify the 
levels of the pfhrp2 protein (Cheng et al., 2014) in a sample was only performed in 
three studies (Gamboa et al., 2010; Dorado et al., 2016; Rachid Viana et al., 2017).  
The meta-analysis was conducted using Bayesian methods with the objective of 
estimating the mean proportion of pfhrp2 and pfhrp3 gene deletions and the 
respective log odds ratio. In this analysis, a Multinomial distribution was assumed for 
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the 2 x 2 frequency table of each study. To describe study heterogeneity, a Dirichlet 
distribution was additionally assumed for the joint probabilities of the combined 
pfhrp2 and pfhrp3 genotypes from each study. The resulting statistical model was 
the Multinomial-Dirichlet distribution (MDD). The analysis was performed assuming a 
single MDD for all studies (global analysis), and a different MDD for studies from 
Africa and South America. 
In terms of Bayesian specification, a Gamma distribution with both shape and scale 
hyperparameters equal to 0.001 was assumed for each parameter of the MDD in 
order to obtain non-informative and independent prior distributions. Markov Chain 
Monte Carlo methods via the software JAGS (http://mcmc-jags.sourceforge.net/) 
were used to perform posterior inference. A single chain of 110,000 iterations were 
generated for each analysis, where the first 10,000 iterations were considered the 
respective burn-in period. A lag of 10 iterations assured a total of 10,000 
independent values of the posterior distributions. The respective script and output 
files are available as Supplementary Data 2 and 3.  
 
2.4 Statistical inference 
To analyse whole-genome sequencing data from experimental crosses, the Clopper-
Pearson confidence interval at 95% was used to estimate the prevalence of pfhrp2 
and pfhrp3 gene deletions. The Fisher’s exact test was performed to compare the 
prevalence of each gene deletion across different experimental populations under a 
5% significance level. Since whole-genome sequencing samples from the field were 
based on different sampling strategies (not entirely random), only the observed 
prevalence of pfhrp2 and pfhrp3 deletions was reported here.  
With respect to meta-analysis, statistical inference was based on the mean 
prevalence of pfhrp2 and pfhrp3 deletions and the corresponding odds ratio in log 
scale (log ) using the posterior mean and the 95% credible interval of these 
parameters. In particular, the log  was calculated to measure the strength of 
association between pfhrp2 and pfhrp3 deletions. A positive value of log provided 
evidence for a propensity of pfhrp2 and pfhrp3 deletions occurring together in the 
same infected individual, whereas a negative value suggested a propensity for a 
deleted pfhrp2 gene occurring together with an intact pfhrp3 gene (or the other way 
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around). The whole statistical analysis was performed in the base R software version 
3.3.2 (https://www.r-project.org/).  No specific packages were used in this analysis.  
 
3. Results  
3.1 Deletions of pfhrp2/pfhrp3 genes in lab strains  
Genomic data from 3D7, HB3, DD2, 7G8, and GB4 lab lines were interrogated as 
proof-of-principle that the datasets captured the known pfhrp2 and pfhrp3 genotypes 
of each line. Read coverage of pfhrp2 gene was effectively zero in DD2 with normal 
coverage for pfhrp3 (Table 1 and Figure 1A).  There was zero coverage of pfhrp3 in 
both genome data sets from the HB3 line (Figure 1B). In the DD2 line, the deletion of 
pfhrp2 was included in a regional loss spanning the positions of 1,368,994 and 
1,383,070 (14kb) on chromosome 8. With respect to the HB3 line, there was 
evidence for a large deleted region of about 47kb spanning the positions 2,807,552 
and 2,854,158 at chromosome 13, where pfhrp3 is located. Although pfhrp2 appears 
intact in the HB3 line, a possible deletion might also be present in an upstream 
region of this gene at chromosome 8 (1,392,075-1,398,230; 6kb). This region 
includes two genes encoding distinct PHISTa-like proteins with unknown function 
(PF_0832200 and PF_0832300). As positive controls for the presence of both pfhrp2 
and pfhrp3 genes, the genomic data of the 7G8 and GB4 lines showed sufficient 
coverage for the extended pfhrp2 and pfhrp3 loci on their respective chromosomes 
(Supplementary Figure 2).  
 
3.2 Deletions of pfhrp2 and pfhrp3 genes in the experimental crosses  
Data from different experimental crosses were analysed in order to understand the 
inheritance of pfhrp2 and pfhrp3 deletions and to estimate the frequency of 
spontaneously occurring gene deletions during sexual recombination between 
parental strains with intact genes at both loci.  
As expected, genomic data of HB3 x DD2 could identify single or double pfhrp2 and 
pfhrp3 deletions in the respective progeny (Table 2). In particular, the detection of 
clones with deletions of a single gene demonstrated the ability to uniquely map reads 
onto these genes sharing a high sequence homology. There were 21 out of 37 
clones with pfhrp2 deletion (95%CI=(39.5%;72.9%)). This result showed that this 
deletion could be maintained upon genetic crossing and its frequency did not depart 
from a Mendelian prediction. As expected from two genetically unlinked genes, the 
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inheritance patterns of pfhrp2 and pfhrp3 deletions appears to be independent of 
each other (p=0.40; Fisher’s exact test excluding the frequency of mixed calls).  Note 
that there were two samples with possible mixed genotypes (i.e., both deleted and 
intact forms were present at one locus) for pfhrp2 gene (Figure 2A; Table 2). Split-
read analysis revealed the presence of split reads in the flanking position defining 
the beginning of the deletion (Supplementary Figure 3A). However, these split reads 
appeared to be orphaned of the respective second fragment, suggesting a possible 
insertion-deletion.   
In 3D7 x HB3, there were no clones lacking pfhrp3 (0 out of 19 clones; 
95%CI=(0.0%;16.9%)). However, this result should be interpreted with caution due 
to the small number of clones analyzed (n=19). In the alternative HB3 x DD2, there 
were five out of 37 clones with evidence of pfhrp3 deletions (95%CI=(4.3%;28.8%)). 
However, this frequency was not statistically different from the one observed in the 
3D7 x HB3 cross (Fisher exact’s test, p=0.15). Therefore, under these lab conditions, 
the segregation of the pfhrp3 deletion derived from HB3 might not affected by the 
second parental strain used in the genetic crosses. 
No evidence was found for any pfhrp2 or pfhrp3 deletion in 7G8 x GB4 (n=38; 
CI95%=(0.0%;9.2%)). Combining this result with the one from 3D7 x HB3 where no 
pfhrp2 deletions were also found, the overall prevalence of spontaneously 
generating a pfhrp2 deletion from parasites with intact genes was estimated to be 
less than 6% (n=58 clones; 95%CI=(0.0%;6.2%)). The spontaneous generation of 
pfhrp2 and pfhrp3 deletions in these experimental settings appears to be a relatively 
rare genomic event, but larger sample sizes are needed to investigate this further.     
 
3.3 Global analysis of deletions in field Isolates 
The analysis proceeded with the detection of pfhrp2 and pfhrp3 deletions in 1,940 
field isolates (Table 3). There was a predominance of samples from Southeast Asia, 
namely, Cambodia (n=499), Thailand (n=219), and Vietnam (n=180), where the 
frequency of the deletions is currently unknown. There was also a total of 25 isolates 
from South America, namely, Colombia and Peru, two countries where the presence 
of parasites lacking pfhrp2 and pfhrp3 has been reported.  
The stringent deletion calling algorithm detected a total of 34 isolates with evidence 
for deletion in either gene (Table 3; Supplementary Figure 4). There were nine 
isolates (0.5%) with evidence for pfhrp2 deletions, where two Kenyan isolates were 
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the only ones detected with almost zero coverage. The remaining seven isolates 
appear to be mixed genotype calls. Figure 2B illustrates two examples of coverage 
profiles from Cambodia and Vietnam with evidence for these mixed infections. 
However, when the read alignment files were mined, there was no clear evidence for 
the presence of split reads and, therefore, mixed calls could have just resulted from 
random fluctuations of coverage (Supplementary Figure 3B).  
In contrast to pfhrp2, there was a higher frequency of samples with possible pfhrp3 
deletions (1.4%, 28 out of 1,940; Supplementary Figure 4). Interestingly, the 
geographical location of these samples was spread over Southeast Asia (India, n=1; 
Cambodia, n=14; Laos, n=1; Thailand, n=1; Vietnam, n=8). Outside Southeast Asia, 
only two isolates were found with this gene deletion, one from Peru and another from 
Kenya. Finally, five samples showed evidence for possible mixed genotype call for 
pfhrp3 (Cambodia, n=3; Vietnam, n=2). Again, these mixed genotypes could not be 
confirmed by the split-read analysis. 
 
3.4 Meta-analysis of pfhrp2/pfhrp3 deletions 
To further understand the level of association between pfhrp2 and pfhrp3 deletions, 
a meta-analysis was performed using data from ten studies of which six were from 
South America and four from Africa. These ten studies encompassed 15 different 
sites in total (Table 4). The sample sizes ranged from 25 (Bolivia) to 253 (Colombia). 
According to a separate MDD for data of each continent, the highest estimated 
probability of pfhrp2 and pfhrp3 deletions were observed in Ghindae/Massawa of 
Eritrea (HRP2-=0.58; 95%CI=(0.45;0.71) and Bolivia (HRP3-=0.64; 
95%CI=(0.46;0.81)), respectively. The study from Guyana was the only one where 
no pfhrp2 and pfhrp3 deletions were observed. Interestingly, data from Puerto 
Lempira in Honduras showed evidence for the existence of a high percentage of 
pfhrp3 deletions (HRP3-=0.44; 95%CI=(0.33;0.55)) in the presence of an intact pfhrp2 
gene (HRP2-=0.01; 95%CI=(0.00;0.03)). These data agreed with the Honduran origin 
of HB3 line (Bhasin and Trager, 1984) and a possible genetic selection of pfhrp3 
deletion not related to the use of HRP2-detecting RDT in this country.    
At the continent level, the meta-analysis suggested a higher mean proportion of 
pfhrp2 deletions in the African studies  than in the ones from South America 
(posterior means of 0.28 and 0.14, respectively; Figure 3A). Interestingly, the mean 
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proportion of pfhrp3 deletions appeared not to substantially vary between studies 
from different continents (posterior means of 0.40 and 0.34, respectively; Figure 3A). 
Since pfhrp2 and pfhrp3 genes share high homology in nucleotide sequence (85-
90%) in the 3D7 reference genome, a putative positive association was 
hypothesized between the frequencies of pfhrp2 and pfhrp3 deletions due to a 
shared selection pressure resulting from the use of HRP2-detecting RDT. The point 
estimates of the log odds ratio varied from -5.55 (Beni in Bolivia) to 10.86 (7 
Departments of Colombia) (Table 4). No evidence for association between pfhrp2 
and pfhrp3 deletions was found for Beni in Bolivia, Pará state in Brazil, French 
Guiana, Georgetown in Guyana, and Puerto Lempira in Honduras. This lack of 
association could be explained by the low frequency of pfhrp2 deletions. Evidence 
for a positive association was in turn found for ten sites (Gash Barka/Debub and  
Ghindae/Massawa in Eritrea, Accra and Cape Coast in Ghana, Mbita in Kenya, Acre 
and Rondonia states from Brazil, both studies from Colombia, and Paramaribo in 
Suriname). The Peruvian study was the only one providing evidence for a negative 
association between the pfhrp2 and pfhrp3 deletions (n=148; log =-1.05; 95%CI=(-
1.74;-0.36)). When these results were combined using a separate MDD for the data 
of each continent, there was evidence for a positive mean association between 
pfhrp2 and pfhrp3 deletions in both Africa and South America (Figure 3A). Since the 
data from the studies analysed referred to the combined genotype of the pfhrp2 and 
pfhrp3 genes at the individual level, the positive association between the 
corresponding genotype frequencies was indicative of a propensity of the pfhrp2 and 
pfhrp3 deletions occurring in the same infected sample. A similar result was obtained 
when the whole data set was analysed using a single MDD. Finally, this positive 
association was negatively but weakly correlated with the mean log odds of pfhrp2 
deletions in the global analysis and the analysis of Africa and South America data 
(Pearson’s correlation coefficient=-0.07, -0.11, and -0.09, respectively; Figure 3B).  
When assessing the data to be included in the meta-analysis, the data of the 
Ghanaian study showed some inconsistencies with respect to the pfhrp2 and pfhrp3 
gene deletions. In particular, there were some positive RDT samples with 
contradicting evidence for deletions of both pfhrp2 and pfhrp3 genes (see Figure 3 of 
Amoah et al., 2016). Meta-analysis was then repeated without the data from this 
study. There was evidence for a minor impact of this study on the posterior 
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distributions of mean probability pfhrp2 and pfhrp3 deletions irrespective of the 
analysis (Figure 3A). The major impact was observed for the posterior distribution of 
average log odds ratio between probability of pfhrp2 and pfhrp3 deletions in studies 
from Africa. However, qualitatively, data still suggested a positive association 
between the probability of pfhrp2 and pfhrp3 deletions in those studies. 
 
4. Discussion 
This study demonstrates the potential use of whole-genome sequencing data to 
detect pfhrp2 and pfhrp3 deletions in laboratory and field isolates of P. falciparum. 
Genomic data from experimental crosses also showed the potential of identifying 
possible polyclonal samples with a mix of parasites exhibiting deleted and non-
deleted genes. However, this potential could not be confirmed in the field samples 
where all samples with possible mixed genotypes failed to show evidence for the 
presence of split reads in the respective read alignments. Since sequence diversity 
is the hallmark of pfhrp2 and pfhrp3 (Baker et al., 2010), the low coverage of these 
samples could have resulted from monoclonal infections with parasites showing 
sequences of pfhrp2 and pfhrp3 very different from the ones in the 3D7 reference 
genome. This investigation was, however, out of the scope of this study.      
The genomic data of field samples could identify parasites lacking pfhrp2 and pfhrp3. 
In contrast, a previous global analysis of these genes did not report any of these 
gene deletions using PCR amplification (Baker et al., 2010). This discrepancy in 
findings could be explained by the small sample sizes from each country in the 
Baker et al analysis, the challenge of identifying gene deletions hidden in polyclonal 
infections using PCR, and the possible problems associated with the molecular 
investigation of these gene deletions, as discussed in depth elsewhere (Cheng et al., 
2014; Parr et al., 2018).  
Data from the experimental crosses provided invaluable information on the 
segregation pattern of pfhrp2 and pfhrp3 deletions. In 3D7 x HB3 and HB3 x DD2, 
there was evidence for a lower frequency of pfhrp3 gene deletion in the respective 
progeny than the one predicted by Mendelian segregation. A sampling bias towards 
self-fertilization of the parental line carrying the pfhrp3 gene was clearly ruled out as 
the progeny of 3D7 x HB3 and HB3 x DD2 were mostly recombinant. In the past, it 
was hypothesized that parasites carrying pfhrp3 gene have a competitive advantage 
in the laboratory conditions or in the chimpanzee host used in the genetic crosses 
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(Wellems et al., 1987). A recent study has reported evidence for similar distributions 
of multiplication rates between 3D7 and HB3 in lab cultures (Murray et al., 2017). 
This study also suggested similar distributions of multiplication rates in heterologous 
cultures between DD2 and HB3 lines. Bringing these results together, the chance of 
finding rare pfhrp3-deleted progeny in 3D7 x HB3 and HB3 x DD2 is possibly due to 
be a better adaptation of the parasites carrying pfhrp3 in the host instead of in vitro 
conditions. This tendency appears to explain the near-absence of pfhrp3 deletions in 
whole-genome samples from African countries where malaria transmission intensity 
is higher than elsewhere. In general, transmission intensity is positively correlated 
with the frequency of polyclonal infections (Fola et al., 2017; Manjurano et al., 2011) 
and, therefore, populations from high transmission settings are likely to purge pfhrp3-
deleted parasites in circulation by genetic crossing in the same host. If this 
interpretation is correct, these deletions can only be maintained in populations with 
low transmission intensities.  This prediction from the genetic crosses is to some 
extent supported with data from field samples where pfhrp3 deletions were only 
found across Southeast Asia and South America. In the same line of evidence, 
meta-analysis suggested similar posterior distribution of the mean proportion of 
pfhrp3 deletions between African sites in relatively low intensity transmission areas 
(i.e., Gash Barka and Debub regions in Eritrea, Mbita in Kenya, Cape Coast and 
Accra in Ghana) and the South American sampling sites.    
Data of HB3 x DD2 could not rule out a Mendelian segregation of the pfhrp2 deletion 
in the respective progeny. Therefore, under experimental conditions, this genetic 
variant can be propagated through sexual recombination. In a natural environment, 
the segregation of this deletion is likely to be affected by factors related to parasite 
adaptation to the host, malaria transmission intensity as reflected by the number of 
polyclonal infections (e.g., multiplicity of infection) in the population, uncertain impact 
of loss of flanking loci and, finally, the selective pressure exerted by HRP2-based 
diagnostic testing. In the same genetic cross, pfhrp3 deletion showed a lower 
frequency than the one expected by a Mendelian prediction. Similarly, no clones 
lacking pfhrp3 were observed in the progeny of 3D7 x HB3. This unusual pattern of 
inheritance can be explained by a strong selective advantage of that progeny to the 
lab hosts (e.g., chimpanzees) and/or the experimental conditions of the in vitro 
cultures, as hypothesized previously (Wellems et al., 1987). Evidence for an 
independent segregation of pfhrp2 and pfhrp3 deletions in HB3 x DD2 suggests that 
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the selective advantage to the genetic cross conditions is driven by pfhrp3 alone, 
generating distinct inheritance patterns of pfhrp2 and pfhrp3 deletions.   
From the malaria control standpoint, it was important to estimate the probability of 
generating a spontaneous pfhrp2 deletion. According to the data from the 3D7 x HB3 
and HB3 x DD2 crosses, this probability appears to be less than 6%. This estimate 
would, however, have benefited from larger sample sizes to reduce  estimation 
uncertainty.  
In contrast to the meta-analysis where the mean prevalence of pfhrp2 deletions was 
globally estimated at ~17%, field samples harbouring these deletions were nearly 
absent, a finding which is in agreement with a previous global analysis of pfhrp2 
deletions (Baker et al., 2010). However, this apparent low prevalence of pfhrp2 
deletions in the field isolates should be interpreted with caution. These field samples 
have a significant selection bias, because they were collected under different 
conditions and for distinct scientific purposes. 
The meta-analysis provided global estimates for the mean frequency of pfhrp2 and 
pfhrp3 deletions, respectively, though it has some caveats. Firstly, the studies 
considered different populations, such as asymptomatic children (Amoah et al., 
2016; Beshir et al., 2017), children and adults (Menegon et al., 2017), or 
symptomatic patients (Abdallah et al., 2015; Dorado et al., 2016; Rachid Viana et al., 
2017). Secondly, some studies referred to historical samples available from the 
respective populations  (Trouvay et al., 2013) or to data passively collected from 
health centres or clinics (Akinyi Okoth et al., 2015). These data are intrinsically 
biased and do not reflect a true random sampling of the population. Thirdly, the 
studies were conducted in different years and the mean prevalence estimates of 
pfhrp2 and pfhrp3 deletions should be regarded as aggregated averages over the 
time period of the studies. Fourthly, some studies from Africa and Asia were 
excluded from this analysis, because they analysed only a subset of samples with 
negative HRP2-based RDT results.  
An overall difficulty associated with the meta-analysis was related to the data quality 
of the reported pfhrp2 and pfhrp3 deletions. As mentioned earlier, some concerns 
about data quality were raised for the Ghanaian study where, for example, RDT 
positive samples lacked both pfhrp2 and pfhrp3 genes (Amoah et al., 2016). In 
theory, RDT positivity could be obtained from people without current infection, but 
with the HRP2 protein still circulating in the blood. Therefore, these samples should 
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have been discarded as putative pfhrp2 and pfhrp3 deletions. This and other 
scientific inconsistencies found in the literature motivated a general discussion on 
how to carefully investigate and interpret evidence for these deletions (Cheng et al., 
2014; Woodrow and Fanello, 2017; Parr et al., 2018). Current recommendations 
(Cheng et al., 2014) require that initial evidence should be gathered by testing if a 
sample is confirmed as either microscopy or PCR positive. Confirmatory evidence for 
gene deletion should contemplate the molecular amplification of different gene 
segments of pfhrp2 and pfhrp3 and the amplification of the respective flanking 
regions. An antigen analysis where the presence of the pfHRP2 protein is detected 
by ELISA or using a different non-pfHRP2-detecting RDT should also be performed. 
Unfortunately, all of these recommendations were not followed in the published data 
included in this study and, therefore, the meta-analysis might reflect the data quality 
of the original studies. Recently, a new testing algorithm was proposed for the 
investigation of pfhrp2 and pfhrp3 deletions (Parr et al., 2018). This algorithm 
appeared to produce a tenfold improvement in the underlying limit of detection, but 
remains to be tested in different populations and lab conditions. As a future 
alternative, the richness of genomic data together with a decrease in the sequence 
cost show promise to revolutionize the investigation not only of pfhrp2 and pfhrp3 
deletions, but also of their relationship with other genetic variants important for 
malaria control and treatment.   
In summary, the genomic data of the HB3 x DD2 cross showed evidence for a 
Mendelian segregation of pfhrp2 deletion, thus, suggesting no fitness cost of this 
genetic variant in experimental settings. The same genomic data also suggested an 
independent segregation between deletions of pfhrp2 and pfhrp3, as predicted by 
two unlinked genes in the absence of selection. The genomic data from field 
samples were inconclusive about the prevalence of pfhrp2 deletion in natural 
populations due to convenience sampling. However, there was a strong evidence for 
a wide spread of pfhrp3 deletion in Southeast Asia. The meta-analysis enabled to 
infer a positive association between these two gene deletions in the same parasite. 
Notwithstanding the problems and challenges highlighted in the investigation of 
these deletions in field studies, a positive association is consistent with a shared 
selective pressure of these two genes caused by HRP2-based diagnostic testing and 
subsequent treatment. Future studies will help to confirm or disprove this 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
interpretation, thus, helping public health authorities to better decide possible 
changes in current RDT policies.   
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Figure 1: Coverage profiles (dark blue lines) of the lab strains 3D7 (A), HB3 (B), and 
DD2 (C) within pfhrp2 and pfhrp3 loci at chromosomes 8 and 13, respectively. The 
coding region of pfhrp2/pfhrp3 genes and of other genes in the same locus (e.g., 
stevor, riffin and PHIST proteins) are shown in salmon and faded rose, respectively. 
Dashed blue lines represent the average coverage per position at the corresponding 
chromosome. 
 
Figure 2: Examples of coverage profiles with a possible mixed genotype call 
(intact/deletion in the same isolate) for pfhrp2: (A) B1SD and CH3_61 isolates from 
HB3 x DD2 cross and (B) two field samples from Cambodia (CAM245) and Vietnam 
(VIE0101). Split-read analysis confirmed the existence of split reads in the left 
breakpoints of B1SD and CH3_61 (Supplementary Figure 3A). Similar analysis could 
not detect any split reads in the field samples with possible mixed genotype 
(Supplementary Figure 3B). See Figure 1 for further information about the coverage 
profiles.    
 
Figure 3: Posterior densities of the mean probabilities of pfhrp2 and pfhrp3 deletions 
and the mean of the log odd ratio of the combined pfhrp2 and pfhrp3 genotypes (log 
) (A) in separate meta-analyses including or not the Ghana study. Simulated values 
of the bivariate posterior distributions of the mean of the log odds of the HRP2 
deletion and the mean of the log in the meta-analysis of all studies, where R 
denotes the Pearson’s correlation coefficient (B). These posterior inferences were 
based on a single MDD for the global analysis and on a different MDD for data each 
continent.  
 
Supplementary Data 1: Meta-data from the 1970 field samples. 
 
Supplementary Data 2: Model scripts used in meta-analysis. 
 
Supplementary Data 3: Posterior samples obtained from the JAGS for the meta-
analysis including or not the Ghanaian study. 
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Supplementary Figure 1: Sequence analysis of pfhrp2 and pfhrp3 genes in the 3D7 
reference genome. A. Sequence alignment using clustal multiple sequence 
alignment by muscle. B. Uniqueness of the pfhrp2 and pfhrp3 sequences. For each 
position, the uniqueness was calculated as follows. Using sliding window approach 
with a window size of 65 and a step size of 1 the sequences are divided into kmers. 
The number of times the each kmer appears in both gene sequences is stored 
(#kmer_hits). The uniqueness of each position is represented by 1/#kmers_hits. 
 
Supplementary Figure 2: Coverage profiles (dark blue lines) of the 7G8 and GB8 
lines within pfhrp2 and pfhrp3 loci at chromosomes 8 and 13, respectively, as 
explained in Figure 1.  
 
Supplementary Figure 3: Split-read analysis of the pfhrp2 gene for the potential 
polyclonal samples in Figure 2. Visualisation of reads from B1SD and CH3_61 
clones of HB3 x DD2 (A), and CAM245 and VIE0101 from the field samples (B). 
Individual reads are represented by the horizontal coloured lines (red: clipped reads 
and blue: non-clipped reads). The vertical black line indicates the breakpoint of 
where the reads are clipped. The thick horizontal black line represents the gene 
overlapping the genomic region. 
 
Supplementary Figure 4: Coverage profiles (dark blue lines) of the 34 field samples 
with deletions or possible mixed calls for pfhrp2 and pfhrp3 genes. See Figure 2 for 
figure legend. 
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Table 1: Summary of coverage for the different lab lines and corresponding progeny. 
 
Samples Sample size Range of Mean Coverage  
overall pfhrp2 pfhrp3 
3D7 1 122 99 82 
HB3 2 80-100 51-88 0 
DD2 1 122 0 72 
7G8 1 87 98 91 
GB4 1 104 59 90 
3D7 x HB3 19 41-173 15-121 26-115 
HB3 x DD2 35 22-637 0-450 0-329 
7G8 x GB4 38 55-250 35-233 30-206 
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Table 2: Frequency of clones from different lab strains and corresponding 
experimental crosses with no deletion (-), complete deletions (+) and a putative 
mixed genotype (+/-) of pfhrp2 and pfhrp3 and a locus including two PHIST-like 
proteins in the flanking region of pfhrp2 (PF_0832200 and PF_0832300). The 
column ‘line’ refers to the genotype of each parental line in the genetic crosses. 
 
pfhrp2 PHIST-like 
genes 
pfhrp3 Parental line 3D7 x HB3 HB3 x DD2 7G8 x GB4 
+ + + 3D7, 7G8, GB4 3    0 38 
+ - + N/A 15 13 0 
+ - - HB3 0 3 0 
- - + DD2 0 15 0 
- - - N/A 0 2 0 
+ +/- + N/A 1 0 0 
+/- +/- + N/A 0 2 0 
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Table 3: Frequency of field samples with deletion (-) and possible mixed calls (+/-) 
for pfhrp2 and pfhrp3 genes using a flanking region of 1.0kb. Mixed calls could not 
be confirmed by split-read analysis.  
 
Continent Country Sample 
size 
pfhrp2  pfhrp3  
- +/- - +/- 
Africa Burkina Faso 47 0 0 0 0 
 Congo (DR) 66 0 0 0 0 
 Gambia 57 0 0 0 0 
 Ghana 198 0 0 0 0 
 Guinea 92 0 0 0 0 
 Kenya 27 2 0 1 0 
 Malawi 213 0 0 0 0 
 Mali 55 0 0 0 0 
 Nigeria 4 0 0 0 0 
 Tanzania 19 0 0 0 0 
Asia/Oceania Bangladesh 50 0 0 0 0 
 Cambodia 499 0 3 11 3 
 India 2 0 0 1 0 
 Laos 104 0 0 1 0 
 Myanmar 97 0 0 0 0 
 Papua New Guinea 16 0 0 0 0 
 Thailand 219 0 1 1 0 
 Vietnam 180 0 2 6 2 
South America Colombia 13 0 1 0 0 
 Peru 12 0 0 2 0 
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Table 4: Meta-analysis of the association between combined pfhrp2/pfhrp3 genotype 
in data from 15 sites across the world, where n is the sample size, HRP2 and HRP3- 
are the prevalences of pfhrp2 and pfhrp3 deletion, respectively, log  is the 
corresponding odds ratio in log scale, and 95% CI is the 95% credible interval. 
Bayesian estimates were obtained from fitting a different MDD to the data of each 
continent.  
 
Continent Country (Site) n Frequencies of 
pfhrp2/pfhrp3 
genotype 
 Posterior mean (95% CI) 
+/+ +/- -
/+ 
-/- HRP2- HPR3- log  
Africa Eritrea 
(Gash Barka + 
Debub) 
144 81 49 1 13  0.10 
(0.06;0.16) 
0.43 
(0.35;0.51) 
3.05  
(1.37;5.46) 
 Eritrea 
(Ghindae + 
Massawa) 
50 9 10 0 31  0.58 
(0.45;0.71) 
0.77 
(0.65;0.88) 
5.82 
(2.22;15.31) 
 Ghana  
(Accra) 
179 118 29 25 7  0.18 
(0.13;0.24) 
0.21 
(0.15;0.27) 
0.21 
(-0.74;1.09) 
 Ghana  
(Cape Coast) 
109 46 19 14 30  0.40 
(0.31;0.49) 
0.45 
(0.36;0.54) 
1.67 
(0.86;2.53) 
 Kenya  
(Mbita) 
91 69 4 14 4  0.20 
(0.13;0.29) 
0.11 
(0.05;0.18) 
1.57 
(0.14;3.02) 
South 
America 
Bolivia 
(Beni) 
25 7 17 1 0  0.05 
(0.00;0.16) 
0.64 
(0.46;0.81) 
-5.55 
(-
22.69;1.21) 
 Brazil  
(Acre) 
79 45 9 0 21  0.31  
(0.21;0.41) 
0.38 
(0.28;0.48) 
3.34 
(2.12;4.74) 
 Brazil  
(Pará) 
59 29 30 0 0  0.01 
(0.00:0.04) 
0.50 
(0.37;0.62) 
2.56  
(-
16.44;29.37) 
 Brazil  
(Rondonia) 
60 49 9 0 2  0.04 
(0.01;0.10) 
0.19 
(0.10;0.30) 
10.01 
(1.59;36.14) 
 Colombia 
(Amazonas) 
100 43 39 5 13  0.18 
(0.11;0.26) 
0.51 
(0.42;0.61) 
1.13 
(0.03;2.32) 
 Colombia 
(7 Departments) 
253 147 91 0 15  0.06 
(0.03;0.09) 
0.42 
(0.36;0.48) 
10.86 
(2.78;36.35) 
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 French Guiana 
(6 sites) 
81 75 6 0 0  0.00  
(0.00;0.03) 
0.08 
(0.03;0.15) 
4.88 
(-
13.79;29.37) 
 Guyana 
(Georgetown) 
97 97 0 0 0  0.00 
(0.00;0.02) 
0.01 
(0.00;0.04) 
8.60 
(-
17.12;30.22) 
 Honduras 
(Puerto Lempira) 
68 38 30 0 0  0.01 
(0.00;0.03) 
0.44 
(0.33;0.55) 
2.80 
(-
17.12;30.22) 
 Peru 
(Iquitos and 
others) 
148 20 67 29 32  0.41 
(0.33;0.49) 
0.66 
(0.59;0.74) 
-1.05  
(-1.74;-0.36) 
 Suriname 
(Paramaribo) 
78 66 1 9 2  0.14 
(0.07;0.22) 
0.05 
(0.01;0.10) 
2.38 
(0.07;4.87) 
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Fig. 3  
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Highlights 
 
 Deletions of pfhrp2 and pfhrp3 genes segregate independently of each other 
in the lab. 
 Genomic data from experimental crosses identified gene deletions masked in 
polyclonal infections.  
 Both pfhrp2 and pfhrp3 gene deletions are in low frequency worldwide.  
 Deletions of pfhrp3 gene are widespread in Southeast Asia. 
 These gene deletions are under selection globally. 
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